Circular to ConvergeNet shareholders regarding:
- The sale of ConvergeNet's remaining interest in Future Cell to Pepkor, a related party;
- the specific purchase by CMS, a wholly owned subsidiary of ConvergeNet, of 71 478 594 ConvergeNet
ordinary shares from Titan;
- the granting by ConvergeNet of financial assistance, in the form of a loan, to CMS in terms of Section 44
of the Companies Act, to enable it to fund the purchase consideration of the 71 478 594 ordinary shares in ConvergeNet purchased by it from Titan;
and incorporating:
- a notice of General Meeting; and
- a form of proxy (for certificated ConvergeNet shareholders or ConvergeNet dematerialised shareholders
with "own name" registration only).

distributed by